paroxetine has been researched along with quetiapine fumarate in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 5 (27.78) | 2.80 |
| Authors | Studies |
|---|---|
| Baldessarini, RJ; Tarazi, FI; Zhang, K | 1 |
| Denys, D; van Megen, H; Westenberg, H | 1 |
| Altschuler, EL; Kast, RE | 1 |
| Bhanji, NH; Margolese, HC | 1 |
| Corral, M; Kendrick, K; Misri, S; Wardrop, AA | 1 |
| Connor, KM; Davidson, JR; Hoge, EA; LeBeau, RT; Pollack, MH; Simon, NM; Worthington, JJ; Zhang, W | 1 |
| Hayashida, K; Kiriike, N; Matsunaga, H; Nagata, T; Ohya, K; Stein, DJ | 1 |
| Agambaram, V; Brecher, M; Chang, W; McElroy, SL; Merideth, C; Nordenhem, A; Olausson, B; Paulsson, B; Weisler, RH; Young, AH | 1 |
| Chen, PY; Chou, KJ; Huang, MC | 1 |
| Barbui, C; Cipriani, A; Furukawa, TA; Koesters, M; Nosè, M; Omori, IM; Purgato, M; Trespidi, C | 1 |
| Hochfeld, M; Meng, X; Potkin, SG; Preskorn, S | 1 |
| Janse, R; Ter Horst, M; Wolvetang, T | 1 |
| Beyer, JL; Johnson, KG | 1 |
| Bianchi, L; Del Duca, E; Esposito, M; Fargnoli, MC; Giunta, A; Manfreda, V; Troisi, A | 1 |
| Hasegawa, C; Komahashi-Sasaki, H; Maehara, R; Shimoda, K; Yasui-Furukori, N | 1 |
| Boughner, R; Burkhart, K; Dahan, A; Davis, MC; Florian, J; Ford, K; Gershuny, V; Han, X; Ismaiel, OA; Matta, M; Patel, V; Prentice, K; Racz, R; Rouse, R; Sanabria, C; Shah, A; Stone, M; Strauss, DG; van der Schrier, R; Wang, C; Weaver, J | 1 |
| Mostel, E; Patel, S; Wiener, BG | 1 |
| Li, XZ; Liu, JL; Liu, RB; Xian-Yu, CY; Zhang, C; Zhang, J; Zhang, YQ; Zhang, ZX | 1 |
4 review(s) available for paroxetine and quetiapine fumarate
| Article | Year |
|---|---|
Duloxetine versus other anti-depressive agents for depression.
Topics: Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Desvenlafaxine Succinate; Dibenzothiazepines; Duloxetine Hydrochloride; Fluoxetine; Humans; Paroxetine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Thiophenes; Venlafaxine Hydrochloride | 2012 |
Serotonin Syndrome After Methylene Blue Administration During Cardiac Surgery: A Case Report and Review.
Topics: Antipsychotic Agents; Cardiac Surgical Procedures; Female; Humans; Methylene Blue; Middle Aged; Paroxetine; Postoperative Complications; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome | 2016 |
Advances in Pharmacotherapy of Late-Life Depression.
Topics: Antidepressive Agents; Aripiprazole; Depression; Depressive Disorder; Drug Resistance; Duloxetine Hydrochloride; Humans; Paroxetine; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vortioxetine | 2018 |
Clinical outcomes of recommended active pharmacotherapy agents from NICE guideline for post-traumatic stress disorder: Network meta-analysis.
Topics: Cognitive Behavioral Therapy; Humans; Network Meta-Analysis; Paroxetine; Quetiapine Fumarate; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2023 |
6 trial(s) available for paroxetine and quetiapine fumarate
| Article | Year |
|---|---|
Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.
Topics: Adult; Aged; Ambulatory Care; Antipsychotic Agents; Cyclohexanols; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; Delayed-Action Preparations; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Prospective Studies; Quetiapine Fumarate | 2008 |
A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Cognitive Behavioral Therapy; Combined Modality Therapy; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Fluvoxamine; Follow-Up Studies; Humans; Long-Term Care; Male; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2009 |
A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Placebos; Psychiatric Status Rating Scales; Quetiapine Fumarate; Severity of Illness Index; Treatment Outcome | 2010 |
A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dibenzothiazepines; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Electrocardiography; Enzyme Inhibitors; Female; Genotype; Heart Rate; Humans; Isoxazoles; Ketoconazole; Linear Models; Long QT Syndrome; Male; Middle Aged; Paroxetine; Pharmacogenetics; Phenotype; Piperazines; Piperidines; Quetiapine Fumarate; Thiazoles; United States; Young Adult | 2013 |
Effect of Paroxetine or Quetiapine Combined With Oxycodone vs Oxycodone Alone on Ventilation During Hypercapnia: A Randomized Clinical Trial.
Topics: Adult; Analgesics, Opioid; Antidepressive Agents; Benzodiazepines; Carbon Dioxide; Double-Blind Method; Female; Humans; Hypercapnia; Oxycodone; Paroxetine; Quetiapine Fumarate; Respiration; Respiratory Insufficiency | 2022 |
8 other study(ies) available for paroxetine and quetiapine fumarate
| Article | Year |
|---|---|
Olanzapine, quetiapine, and risperidone: long-term effects on monoamine transporters in rat forebrain.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Carrier Proteins; Caudate Nucleus; Cocaine; Dibenzothiazepines; Dopamine Plasma Membrane Transport Proteins; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nucleus Accumbens; Olanzapine; Paroxetine; Pirenzepine; Prosencephalon; Putamen; Quetiapine Fumarate; Radioligand Assay; Rats; Rats, Sprague-Dawley; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tritium | 2000 |
Combination of bupropion, paroxetine and quetiapine as adjuvant treatment for multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bupropion; Chemotherapy, Adjuvant; Dibenzothiazepines; Evidence-Based Medicine; Humans; Multiple Myeloma; Paroxetine; Quetiapine Fumarate; Treatment Outcome | 2004 |
Extrapyramidal symptoms related to adjunctive nizatidine therapy in an adolescent receiving quetiapine and paroxetine.
Topics: Adolescent; Basal Ganglia Diseases; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Nizatidine; Paroxetine; Quetiapine Fumarate | 2004 |
Quetiapine augmentation in lactation: a series of case reports.
Topics: Adult; Antipsychotic Agents; Cyclohexanols; Dibenzothiazepines; Female; Humans; Infant; Infant Behavior; Lactation; Milk, Human; Paroxetine; Quetiapine Fumarate; Risk Assessment; Venlafaxine Hydrochloride | 2006 |
Restless legs syndrome following the combined use of quetiapine and paroxetine.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bipolar Disorder; Dibenzothiazepines; Drug Therapy, Combination; Humans; Male; Middle Aged; Paroxetine; Quetiapine Fumarate; Restless Legs Syndrome | 2010 |
Long-term safety and efficacy of secukinumab in patients with psoriasis and major psychiatric disorders: a case series.
Topics: Adult; Agoraphobia; Antibodies, Monoclonal, Humanized; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Lithium Carbonate; Male; Mental Disorders; Middle Aged; Nordazepam; Panic Disorder; Paroxetine; Psoriasis; Quetiapine Fumarate; Severity of Illness Index; Treatment Outcome; Valproic Acid | 2020 |
A case of mood disorder with severe side effects of antidepressants in association with resistance to thyroid hormone beta with a THRB mutation.
Topics: Aged; Antidepressive Agents; Female; Humans; Mirtazapine; Mood Disorders; Mutation; Paroxetine; Quetiapine Fumarate; Thyroid Hormone Receptors beta; Thyroid Hormone Resistance Syndrome; Thyroid Hormones; Venlafaxine Hydrochloride | 2022 |
A 70-Year-Old Woman Presenting with Confusion and Muscle Spasms Due to Serotonin Syndrome Associated with Paroxetine and Quetiapine Treatment.
Topics: Aged; Female; Humans; Paroxetine; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Syndrome; Spasm | 2022 |